Insider · CIK 0001726988
Charles D. Goodwin II
Files at APYX (Apyx Medical Corp). First filing -, latest -.
Charles D. Goodwin II files SEC Form 4 as CEO and director at APYX (Apyx Medical Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Charles D. Goodwin II has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | APYX Apyx Medical Corp | AGrant or award Stock Option (Option to Buy)derivative | +213,948 | $0.00 | $0 | 213,948 | Jun 15, 2026 |
| May 15, 2025 | APYX Apyx Medical Corp | AGrant or award Stock Option (Option to Buy)derivative | +193,000 | $0.00 | $0 | 193,000 | May 19, 2025 |
| Jan 15, 2025 | APYX Apyx Medical Corp | AGrant or award Stock Option (Option to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jan 17, 2025 |
Questions about Charles D. Goodwin II
Answered from the filings on this page, as of the latest one.
Is Charles D. Goodwin II buying or selling?
Charles D. Goodwin II has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Charles D. Goodwin II's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Charles D. Goodwin II has 0.
Where does Charles D. Goodwin II file Form 4?
Charles D. Goodwin II has filed Form 4 at APYX (Apyx Medical Corp) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.